$RUN

STEELE JEANNA sold $131K of RUN

STEELE JEANNA (Chief Legal & People Officer) sold 9,897 shares of Sunrun Inc. (RUN) at $13.19 ($0.13M total) on 2026-07-06.

Original reporting
SEC EDGAR · STEELE JEANNA
Published Jul 7, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 7, 2026, 9:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RUN
Neutral
high confidence
Mentioned
$RUN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RUNNeutralLow
01

Why it matters

The disclosure updates the insider activity record for RUN but does not provide new company fundamentals, guidance, or regulatory developments.

02

Market read

Traders may monitor insider activity for sentiment, but the transaction size and lack of additional catalysts suggest limited tradable impact.

03

What to watch

No information on total compensation, tax obligations, or whether other insiders sold/bought around the same period; absence of a 10b5-1 plan increases interpretive uncertainty.

Relevance 4/10Novelty 5/10Timing: after-hours/filing date (2026-07-07) for the 2026-07-06 sale disclosure

Background

This is an SEC Form 4 insider transaction for Sunrun Inc. (RUN) filed on 2026-07-07, covering a sale executed 2026-07-06.

Company-level read

Ticker impact

$RUNNeutralHigh confidence
Context

Sunrun insider STEELE JEANNA (Chief Legal & People Officer) sold 9,897 shares on 2026-07-06 at $13.1875/share, totaling ~$130.5K.

Expected impact

Low near-term impact; any effect is likely short-lived unless paired with other disclosures.

Evidence & confidence

The filing is a disclosed insider sale with no 10b5-1 plan and no accompanying company-specific operational/regulatory catalyst in the text.

Market effects

No sector-level read-through provided; this is an isolated insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity/compensation-related and not a bearish signal, especially given the modest dollar amount.

Key entities

  • Sunrun Inc.

    Subject of the Form 4 insider sale disclosure.

  • STEele JEANNA

    Chief Legal & People Officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

$RUNHigh

Goldman Sachs Cut Its Sunrun Target. It Still Sees [44%] Upside

Goldman Sachs and Citi reduced their price targets for Sunrun (RUN) to $11 and $14, respectively, while maintaining Buy ratings. Analysts anticipate a decline in Sunrun's EPS from $1.71 in 2025 to $1.00 by 2027. Sunrun's stock closed at $7.61 on Oct. 7, a 52-week low. The cuts reflect lower expectations for near-term growth and cash generation.

$RUNMed

Why is Sunrun stock sliding today?

Sunrun (RUN) stock fell 2.0% to $7.46 in pre-market trading, continuing a downtrend after price target cuts from Goldman Sachs and Citi, citing lower near-term growth expectations. The stock hit a 52-week low of $7.42, down 62% over the past year. Analysts maintained Buy ratings but reduced targets to $11 and $14, respectively. A large options trade suggests hedging against further downside. The broader market decline and policy uncertainty also weighed on the stock.